Implied Podcast

Axon Enterprise just took a massive beating, crashing over 18% to a 52-week low despite posting a record $909 million in Q3 revenue. The catalyst? Wall Street panicked after management lowered their full-year guidance due to $130 million in delayed federal drone deployments. But are investors missing the bigger picture? In this episode of Implied, we break down why this drop might be a severe market overreaction, how Axon’s underlying software demand remains rock solid, and why their aggressive cash burn is actually a strategic move to bulletproof the supply chain. Tune in to find out if this panic selloff is a warning sign or a rare opportunity to buy the dip.

Hims & Hers Health (HIMS) just took an absolute beating, shedding nearly 12% in a single session and wiping $600 million off its market cap. The culprit? Panic-selling triggered by a looming class action lawsuit and an FTC probe into billing and privacy practices. But with Q3 earnings days away, projected revenue near $893 million, and a massive new rollout in men's health, is Wall Street overreacting to regulatory noise? In this episode of Implied, we break down whether this steep drop into the $23 range is a toxic red flag or a prime discount ahead of a potential post-earnings rebound.

Fidelity National Information Services (FIS) just fell off a cliff, crashing nearly 24% in a single session despite beating third-quarter revenue and earnings estimates. What triggered the market panic? A slashed full-year outlook paired with the sudden departure of its CFO shattered management credibility and prompted an immediate Wall Street downgrade. Yet underneath the chaos, FIS trades at an ultra-low forward P/E of 4.5, generates a 19% free cash flow yield, and boasts insider buying. In this episode of Implied, we break down why the guidance cut terrified investors, whether the banking tech giant can stage a bounce, and if this brutal selloff is a rare bargain or a classic value trap.

Gartner’s stock just suffered a brutal 14% nosedive down to $202, completely wiping out its recent run-up. The catch? The research giant actually crushed Q3 earnings with a 30% jump in profit and raised full-year guidance across the board. So why the massive selloff? Slowing core top-line growth, missed contract exit rate targets, and a stock that was simply priced for perfection. In this episode of Implied, we break down whether this steep drop exposes real cracks in enterprise tech demand… or sets up a compelling, cash-rich rebound opportunity for patient investors.

Lumentum just suffered a brutal 18% selloff after Marvell Technology announced a massive $115 billion all-stock takeover—the biggest tech merger of the year. Instead of celebrating, Wall Street panicked over heavy dilution, execution risks, and a distant 2028 closing date, sending both stocks into a tailspin. But with Lumentum posting 109% revenue growth on explosive AI optical demand and shares trading at a steep discount to the implied deal price, is this a rare mispricing for value hunters to exploit? In this episode of Implied, we break down the math behind the crash, the antitrust hurdles ahead, and why this optical powerhouse might stage a major rebound.

Coinbase just went into freefall, plunging 25% in a single morning after a brutal Q3 earnings report, a massive $2.2 billion insider stock sale plan, and a sector-wide crypto shock triggered by a $6.3B exploit at rival Binance. While transaction revenue dropped 44% and retail volumes dried up, the company is quietly building momentum in prediction markets, AI-agent trading, and its USDC stablecoin engine. In this episode of Implied, we break down what caused this historic crash and whether this massive selloff is a red-flag warning or a rare, high-upside buying opportunity.

Alphabet just shocked the after-hours market with an 8% crash following a Q3 revenue miss. Wall Street had priced in absolute perfection, and when the tech giant fell slightly short on top-line expectations, momentum traders immediately hit the panic button. But with a fortress balance sheet, incredibly strong Cloud margins, and buzzing rumors about OpenAI buying Google TPUs, is this sell-off just an algorithmic mistake? In this episode of Implied, we break down why expectations decoupled from reality and whether this post-earnings panic is actually a rare opportunity to buy the dip. Tune in for the full story!

UniFirst just suffered a total bloodbath, plunging 10% after the FTC signaled its intent to block a massive $5.5 billion buyout from industry giant Cintas. The market instantly wiped out the stock’s acquisition premium, throwing cold water on what seemed like a slam-dunk payday for shareholders. But underneath the regulatory panic lies a fundamentally rock-solid standalone business with more cash than debt and an eight-year streak of dividend hikes. In this episode of Implied, we break down whether this antitrust roadblock is a permanent setback or a rare opportunity for value hunters to scoop up a premium industrial player on the cheap. Dive in to find out if Wall Street's knee-jerk reaction is overblown and where the hidden upside lies!

Brazilian fintech giant XP Inc. just suffered an absolute meltdown, plunging nearly 50% to fresh 52-week lows after a stunning election upset triggered a massive selloff across South American markets. Despite posting over $966M in revenue and double-digit profit growth, XP got caught right in the epicenter of the macro blast as investors hit the panic button over fiscal uncertainty. In this episode of Implied, we break down whether Wall Street’s knee-jerk reaction has created the ultimate buying opportunity, why top analysts were targeting nearly $40 a share just days ago, and if a vicious relief rally is right around the corner. Tune in to see what’s implied behind the crash.

Bloom Energy just posted a massive Q3 print, crushing expectations with a record $1.24 billion in revenue as it rides the surging AI data center wave. So why did the stock suddenly plunge over 11%? Wall Street completely ignored the shiny top-line numbers and severely punished the company after its operating cash flow plummeted into the red. With Treasury yields hovering near 24-year highs, investors are getting incredibly spooked by any sign of a cash drain. In this episode of Implied, we break down whether this steep selloff is a massive overreaction to necessary growth spending, or a warning sign that Bloom’s stretched valuation leaves zero room for error. Tune in to find out if this drop offers a rare, high-upside entry point to play the AI power bottleneck.